165 related articles for article (PubMed ID: 26268788)
1. Adjusting prednisone using blood eosinophils reduces exacerbations and improves asthma control in difficult patients with asthma.
Wark PA; McDonald VM; Gibson PG
Respirology; 2015 Nov; 20(8):1282-4. PubMed ID: 26268788
[TBL] [Abstract][Full Text] [Related]
2. Oral corticosteroid dose changes and impact on peripheral blood eosinophil counts in patients with severe eosinophilic asthma: a post hoc analysis.
Prazma CM; Bel EH; Price RG; Bradford ES; Albers FC; Yancey SW
Respir Res; 2019 May; 20(1):83. PubMed ID: 31053134
[TBL] [Abstract][Full Text] [Related]
3. Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma.
Karpel JP; Nayak A; Lumry W; Craig TJ; Kerwin E; Fish JE; Lutsky B
Respir Med; 2007 Mar; 101(3):628-37. PubMed ID: 16875813
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory effects of high-dose inhaled fluticasone versus oral prednisone in asthma exacerbations.
Belda J; Margarit G; Martínez C; Bellido-Casado J; Casan P; Torrejón M; Brufal M; Rodríguez-Jerez F; Sanchis J
Eur Respir J; 2007 Dec; 30(6):1143-9. PubMed ID: 17690122
[TBL] [Abstract][Full Text] [Related]
5. Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies.
Ortega HG; Yancey SW; Mayer B; Gunsoy NB; Keene ON; Bleecker ER; Brightling CE; Pavord ID
Lancet Respir Med; 2016 Jul; 4(7):549-556. PubMed ID: 27177493
[TBL] [Abstract][Full Text] [Related]
6. High blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthma.
Zeiger RS; Schatz M; Li Q; Chen W; Khatry DB; Gossage D; Tran TN
J Allergy Clin Immunol Pract; 2014; 2(6):741-50. PubMed ID: 25439366
[TBL] [Abstract][Full Text] [Related]
7. Blood eosinophil count correlates with severity of respiratory failure in life-threatening asthma and predicts risk of subsequent exacerbations.
Yii ACA; Tay TR; Puah SH; Lim HF; Li A; Lau P; Tan R; Neo LP; Chung KF; Koh MS
Clin Exp Allergy; 2019 Dec; 49(12):1578-1586. PubMed ID: 31310686
[TBL] [Abstract][Full Text] [Related]
8. Sputum in severe exacerbations of asthma: kinetics of inflammatory indices after prednisone treatment.
Pizzichini MM; Pizzichini E; Clelland L; Efthimiadis A; Mahony J; Dolovich J; Hargreave FE
Am J Respir Crit Care Med; 1997 May; 155(5):1501-8. PubMed ID: 9154849
[TBL] [Abstract][Full Text] [Related]
9. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia.
Nair P; Pizzichini MM; Kjarsgaard M; Inman MD; Efthimiadis A; Pizzichini E; Hargreave FE; O'Byrne PM
N Engl J Med; 2009 Mar; 360(10):985-93. PubMed ID: 19264687
[TBL] [Abstract][Full Text] [Related]
10. Effects of oral prednisone on sputum eosinophils and cytokines in patients with severe refractory asthma.
Dente FL; Bacci E; Bartoli ML; Cianchetti S; Costa F; Di Franco A; Malagrinò L; Vagaggini B; Paggiaro P
Ann Allergy Asthma Immunol; 2010 Jun; 104(6):464-70. PubMed ID: 20568377
[TBL] [Abstract][Full Text] [Related]
11. Inhaled fluticasone propionate is effective as well as oral prednisone in reducing sputum eosinophilia during exacerbations of asthma which do not require hospitalization.
Di Franco A; Bacci E; Bartoli ML; Cianchetti S; Dente FL; Taccola M; Vagaggini B; Zingoni M; Paggiaro PL
Pulm Pharmacol Ther; 2006; 19(5):353-60. PubMed ID: 16289980
[TBL] [Abstract][Full Text] [Related]
12. Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal.
in't Veen JC; Smits HH; Hiemstra PS; Zwinderman AE; Sterk PJ; Bel EH
Am J Respir Crit Care Med; 1999 Jul; 160(1):93-9. PubMed ID: 10390385
[TBL] [Abstract][Full Text] [Related]
13. Chronic oral corticosteroids use and persistent eosinophilia in severe asthmatics from the Belgian severe asthma registry.
Graff S; Vanwynsberghe S; Brusselle G; Hanon S; Sohy C; Dupont LJ; Peche R; Michils A; Pilette C; Joos G; Louis RE; Schleich FN
Respir Res; 2020 Aug; 21(1):214. PubMed ID: 32787967
[TBL] [Abstract][Full Text] [Related]
14. Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma.
Fish JE; Karpel JP; Craig TJ; Bensch GW; Noonan M; Webb DR; Silverman B; Schenkel EJ; Rooklin AR; Ramsdell JW; Nathan R; Leflein JG; Grossman J; Graft DF; Gower RG; Garay SM; Frigas E; Degraff AC; Bronsky EA; Bernstein DI; Berger W; Shneyer L; Nolop KB; Harrison JE
J Allergy Clin Immunol; 2000 Nov; 106(5):852-60. PubMed ID: 11080706
[TBL] [Abstract][Full Text] [Related]
15. Role of local eosinophilopoietic processes in the development of airway eosinophilia in prednisone-dependent severe asthma.
Sehmi R; Smith SG; Kjarsgaard M; Radford K; Boulet LP; Lemiere C; Prazma CM; Ortega H; Martin JG; Nair P
Clin Exp Allergy; 2016 Jun; 46(6):793-802. PubMed ID: 26685004
[TBL] [Abstract][Full Text] [Related]
16. Value of peripheral blood eosinophil markers to predict severity of asthma.
Casciano J; Krishnan JA; Small MB; Buck PO; Gopalan G; Li C; Kemp R; Dotiwala Z
BMC Pulm Med; 2016 Jul; 16(1):109. PubMed ID: 27473851
[TBL] [Abstract][Full Text] [Related]
17. Burden of Chronic Oral Corticosteroid Use by Adults with Persistent Asthma.
Zeiger RS; Schatz M; Li Q; Chen W; Khatry DB; Tran TN
J Allergy Clin Immunol Pract; 2017; 5(4):1050-1060.e9. PubMed ID: 28215604
[TBL] [Abstract][Full Text] [Related]
18. Exacerbation risk in severe asthma is stratified by inflammatory phenotype using longitudinal measures of sputum eosinophils.
Walsh CJ; Zaihra T; Benedetti A; Fugère C; Olivenstein R; Lemière C; Hamid Q; Martin JG
Clin Exp Allergy; 2016 Oct; 46(10):1291-302. PubMed ID: 27214328
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials.
Hanania NA; Korenblat P; Chapman KR; Bateman ED; Kopecky P; Paggiaro P; Yokoyama A; Olsson J; Gray S; Holweg CT; Eisner M; Asare C; Fischer SK; Peng K; Putnam WS; Matthews JG
Lancet Respir Med; 2016 Oct; 4(10):781-796. PubMed ID: 27616196
[TBL] [Abstract][Full Text] [Related]
20. Ciclesonide reduces the need for oral steroid use in adult patients with severe, persistent asthma.
Bateman E; Karpel J; Casale T; Wenzel S; Banerji D
Chest; 2006 May; 129(5):1176-87. PubMed ID: 16685007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]